GENE ONLINE|News &
Opinion
Blog

Antibody Therapy
Astellas’ Zolbetuximab Meets Phase 3 Endpoints In Gastric And GEJ Cancers
2022-12-16
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
F-star Therapeutics Signs On to invoX Pharma for $161 Million to Stay Afloat
2022-06-24
Vaccines Against Cancers May Be the Future
2022-05-30
AstraZeneca’s Covid-19 Booster and Antibody Cocktail Retains Neutralizing Ability against Omicron
2021-12-27
Moderna Inks Deal with AbCellera to Develop Therapeutic Antibodies for mRNA Medicines
2021-09-15
Aridis Pharmaceuticals’ Antibody Shows Early Promise in the Fight Against COVID-19
2021-07-28
COVID-19: After Lilly, Regeneron Bags EUA for its Antibody Therapy
2020-11-24
Lilly Partners with Samsung Biologics to Boost Delivery of COVID-19 Antibody Treatments
2020-11-19
Celltrion Announces Positive Phase 1 Results for COVID-19 Antibody Therapy
2020-11-12
R&D
Roche, Innovent Sign Billion Dollar Deal for Bispecific Antibodies
2020-06-11
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
EVENT
Scroll to Top